SCD gene therapy approaches using CRISPR, gene therapy, and base editing show different stem cell outcomes in a mouse study.

GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...

Novo Nordisk ((NVO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up In addition to the prolonged pain and suffering endured by sickle ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, ...

A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers. A bone marrow transplant process ...

If you or someone you know has sickle cell disease (SCD), you may have heard of Lyfgenia, one of two gene therapies approved for this condition. Gene therapies are the only treatments for SCD that can ...

Please provide your email address to receive an email when new articles are posted on . Ninety percent of patients with sickle cell disease survived at least 7 years after allogeneic HCT. A majority ...

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook Industry Focus: Cell & Gene Therapy Download the latest edition Beyond its scientific novelty, the study addresses a critical gap in ...

A blood sample drawn from a sickle cell disease patient on March 8, 2024, at Cook Children's Hematology and Oncology in Fort Worth. Sickle cell disease stems from an inherited gene mutation that warps ...